Should You Buy, Sell or Hold AXTI Stock After Its Strong Q3 Results?
AXT, Inc. (AXTI) reported Q3 2026 revenue of $73.4M, up 162% YoY, with non-GAAP EPS at 41 cents. InP sales reached $54.3M, 74% of revenue. AXTI stock surged 190.8% YTD, outperforming peers. Q4 guidance: non-GAAP EPS 57-59 cents, revenue ~$90M. Risks include China exposure and capacity execution. AXTI trades at 24.43X forward P/E, 2.8X industry average.
How this was made

The 30-second read
Why it matters
The earnings beat and raised guidance are likely to attract short‑term buying, but valuation and geopolitical risks temper the rally.
Market read
Strong earnings and guidance make AXTI a near‑term buying candidate, though high valuation and China exposure pose downside risks.
What to watch
Potential dilution from $545M Tongmei investment and export‑permit delays may pressure margins.
Background
AXTI reported a breakout Q3 with record revenue and margin expansion, and issued optimistic Q4 guidance.
Ticker impact
Q3 2026 results show revenue $73.4M (+162% YoY) and non‑GAAP EPS 41¢, plus Q4 guidance of 57‑59¢ EPS.
likely upside as market prices in higher earnings and guidance
Revenue beat and margin expansion signal growth; guidance exceeds consensus, reducing downside risk.
Market effects
Highlights strength of AI‑related InP substrate market, may lift peers in optical networking.
China‑based manufacturing exposure could affect sentiment on China‑linked tech stocks.
Reinforces bullish view on AI infrastructure supply chain globally.
Counterpoint
Valuation premium (24.4× forward P/E) and China export risk could cap upside.
Key entities
- companyAXTI
AXT, Inc., a provider of indium phosphide substrates for AI data‑center networking.



